Literature DB >> 8980289

C3 production of cultured human epidermal keratinocytes is enhanced by IFNgamma and TNFalpha through different pathways.

T Terui1, K Ishii, M Ozawa, N Tabata, T Kato, H Tagami.   

Abstract

We investigated the regulation of C3 production by human cultured epidermal keratinocytes by enzyme-linked immunosorbent assay. The results showed that IFNgamma and TNFalpha enhanced the synthesis of C3 by epidermal keratinocytes in a concentration-dependent manner. Moreover, a protein kinase C (PKC) inhibitor blocked C3 production, whereas PMA enhanced it. There was a synergistic effect between IFNgamma and TNFalpha. In experiments to investigate the role of protein tyrosine kinase (PTK) in C3 production, we found that treatment with herbimycin A, a specific inhibitor for the c-Src-related PTK, caused significant enhancement of the C3 production induced by IFNgamma or TNFalpha, suggesting that c-Src-type PTK(s) provides a negative signal to C3 production. Each competitive inhibitor of PTK, genistein or tyrphostin, substantially increased the C3 production by IFNgamma at lower concentrations, although each agent had little effect on TNFalpha-associated production of C3 at the same concentrations. The data show that pro-inflammatory cytokines IFNgamma and TNFalpha synergistically augment C3 production by epidermal keratinocytes by different pathways.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8980289     DOI: 10.1111/1523-1747.ep12285633

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  Human monocyte-derived dendritic cells are chemoattracted to C3a after up-regulation of the C3a receptor with interferons.

Authors:  Ralf Gutzmer; Margarete Lisewski; Jörg Zwirner; Susanne Mommert; Carola Diesel; Miriam Wittmann; Alexander Kapp; Thomas Werfel
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

2.  The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen.

Authors:  Seiji Kawamoto; Ali Yalcindag; Dhafer Laouini; Scott Brodeur; Paul Bryce; Bao Lu; Alison A Humbles; Hans Oettgen; Craig Gerard; Raif S Geha
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

3.  Complement component 3c and tumor necrosis factor-α systemic assessment after Candida antigen immunotherapy in cutaneous warts.

Authors:  Noha M Hammad; Amina A Abdelhadi; Manal M Fawzy; Ayman Marei
Journal:  Braz J Microbiol       Date:  2020-06-27       Impact factor: 2.476

4.  Aberrant activation of the complement system in renal grafts is mediated by cold storage.

Authors:  Sorena Lo; Li Jiang; Savannah Stacks; Haixia Lin; Nirmala Parajuli
Journal:  Am J Physiol Renal Physiol       Date:  2021-05-17

5.  Activated complement component 3 (C3) is required for ultraviolet induction of immunosuppression and antigenic tolerance.

Authors:  C Hammerberg; S K Katiyar; M C Carroll; K D Cooper
Journal:  J Exp Med       Date:  1998-04-06       Impact factor: 14.307

Review 6.  Complement Activation in Inflammatory Skin Diseases.

Authors:  Jenny Giang; Marc A J Seelen; Martijn B A van Doorn; Robert Rissmann; Errol P Prens; Jeffrey Damman
Journal:  Front Immunol       Date:  2018-04-16       Impact factor: 7.561

7.  Plucked hair follicles from patients with chronic discoid lupus erythematosus show a disease-specific molecular signature.

Authors:  Mohammad Shalbaf; Adewonuola A Alase; Anna Berekmeri; Md Yuzaiful Md Yusof; Jelena Pistolic; Mark J Goodfield; Sara Edward; Natalia V Botchkareva; Martin Stacey; Edward M Vital; Miriam Wittmann
Journal:  Lupus Sci Med       Date:  2019-07-14

8.  C3a receptor promotes viral containment in mice inoculated with vaccinia virus at sites of allergic skin inflammation.

Authors:  Lalit Kumar; Bao Lu; Craig Gerard; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2013-05-16       Impact factor: 10.793

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.